Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026 Additional ...
Continued expansion of LYTENAVA (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026Additional European launches expected in 2026Type A meeting request submit ...
The guarantee will enable Ecobank Congo to expand its capacity to finance imports and broader trade operations, helping ...
Forrester Research, Inc. (Nasdaq: FORR) today announced fourth-quarter and full-year financial results for 2025, with contract value (CV) down by 6%, at $292.4 million, compared with the prior year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results